Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Ita...

Por Ponzetti, Clemente, Canciani, Monica, Farina, Massimo, Era, Sara, Walzer, Stefan
Publicado no Clinicoecon Outcomes Res (2016)

Administrative risk quantification of subcutaneous and intravenous therapies in Italian centers utilizing the Failure Mode and Effects Analysis approach

Por Ponzetti, Clemente, Canciani, Monica, Farina, Massimo, Era, Sara, Walzer, Stefan
Publicado no Clinicoecon Outcomes Res (2016)

Recent advances in the surgical care of breast cancer patients

Por Mascaro, Alessandra, Farina, Massimo, Gigli, Raffaella, Vitelli, Carlo E, Fortunato, Lucio
Publicado em 2010